Status:
ACTIVE_NOT_RECRUITING
Collection of Samples of Bone Marrow Aspiration From Patients With Myelodysplastic Syndrome
Lead Sponsor:
Minovia Therapeutics Ltd.
Conditions:
Myelodysplastic Syndromes
Eligibility:
All Genders
18+ years
Brief Summary
The study Objective is to collect samples of bone marrow aspirates and peripheral blood of patients with MDS for use in non-clinical research to investigate mitochondrial function sequence and effect ...
Detailed Description
Mitochondrial dysfunction is often associated with MDS. Studies have shown mitochondrial DNA (mtDNA) mutations in different MDS subtypes; however, their role in the pathogenesis and disease progressio...
Eligibility Criteria
Inclusion
- Male or female patients of 18 years old and up.
- Suspected or previously diagnosed with Myelodysplastic Syndrome.
- Patient able to understand and provide voluntary written informed consent.
Exclusion
- 1\. History of prior allogeneic hematopoietic stem cell transplantation, cell therapy, gene therapy.
Key Trial Info
Start Date :
February 9 2023
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
March 1 2026
Estimated Enrollment :
100 Patients enrolled
Trial Details
Trial ID
NCT06144515
Start Date
February 9 2023
End Date
March 1 2026
Last Update
June 22 2025
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Shaare Zedek Medical Center
Jerusalem, Israel, Israel, 9103102